Michael S. Nakazawa, MD PhD (he/him/his)

Assistant Professor
MD Anderson Cancer Center

I am currently an assistant professor in sarcoma medical oncology at MD Anderson Cancer Center. My previous research focused on drug resistance mechanisms and the tumor microenvironment in soft tissue sarcomas. I am in the clinical investigator track, and my interests are translating promising new therapies to sarcoma patients through clinical trials.

Poster(s):

• (P 110) INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY OF PLEOMORPHIC RHABDOMYOSARCOMA (P-RMS), A PUSH PLATFORM STUDY: OUTCOME OF LOCALIZED AND ADVANCED DISEASE

• (P 111) INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY OF SPINDLE CELL/ SCLEROSING RHABDOMYOSARCOMA (S-RMS), A PUSH PLATFORM STUDY: OUTCOME OF LOCALIZED AND ADVANCED DISEASE

• (P 233) IMMUNE CLASSES OF LEIOMYOSARCOMA DRIVEN BY B CELL INFILTRATE AND CTLA4 EXPRESSION